Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation

BACKGROUND: Letermovir prophylaxis is currently the standard of care for the prevention of cytomegalovirus (CMV) infections in allogeneic hematopoietic stem-cell transplantation (allo-HSCT). However, drug–drug interactions between letermovir and azoles or calcineurin inhibitors and the high financia...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Po-Hsien, Lin, Cheng-Hsien, Lin, Yu-Hui, Chen, Tsung-Chih, Hsu, Chiann-Yi, Teng, Chieh-Lin Jerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940724/
https://www.ncbi.nlm.nih.gov/pubmed/33747424
http://dx.doi.org/10.1177/2040620721998124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940724/
https://www.ncbi.nlm.nih.gov/pubmed/33747424
http://dx.doi.org/10.1177/2040620721998124

Ejemplares similares